189 related articles for article (PubMed ID: 35941108)
1. Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.
García-Gutiérrez L; Fallahi E; Aboud N; Quinn N; Matallanas D
Cell Death Dis; 2022 Aug; 13(8):692. PubMed ID: 35941108
[TBL] [Abstract][Full Text] [Related]
2. Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma.
Romano D; García-Gutiérrez L; Aboud N; Duffy DJ; Flaherty KT; Frederick DT; Kolch W; Matallanas D
Life Sci Alliance; 2022 Oct; 5(10):. PubMed ID: 36038253
[TBL] [Abstract][Full Text] [Related]
3. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.
Matallanas D; Romano D; Yee K; Meissl K; Kucerova L; Piazzolla D; Baccarini M; Vass JK; Kolch W; O'neill E
Mol Cell; 2007 Sep; 27(6):962-75. PubMed ID: 17889669
[TBL] [Abstract][Full Text] [Related]
4. IQGAP1 Is a Scaffold of the Core Proteins of the Hippo Pathway and Negatively Regulates the Pro-Apoptotic Signal Mediated by This Pathway.
Quinn NP; García-Gutiérrez L; Doherty C; von Kriegsheim A; Fallahi E; Sacks DB; Matallanas D
Cells; 2021 Feb; 10(2):. PubMed ID: 33672268
[TBL] [Abstract][Full Text] [Related]
5. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
[TBL] [Abstract][Full Text] [Related]
6. Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells.
Xiang YC; Peng P; Liu XW; Jin X; Shen J; Zhang T; Zhang L; Wan F; Ren YL; Yu QQ; Zhao HZ; Si Y; Liu Y
Acta Pharmacol Sin; 2022 Jun; 43(6):1568-1580. PubMed ID: 34522004
[TBL] [Abstract][Full Text] [Related]
7. Cross-regulation between oncogenic BRAF(V600E) kinase and the MST1 pathway in papillary thyroid carcinoma.
Lee SJ; Lee MH; Kim DW; Lee S; Huang S; Ryu MJ; Kim YK; Kim SJ; Kim SJ; Hwang JH; Oh S; Cho H; Kim JM; Lim DS; Jo YS; Shong M
PLoS One; 2011 Jan; 6(1):e16180. PubMed ID: 21249150
[TBL] [Abstract][Full Text] [Related]
8. The differential effects of wild-type and mutated K-Ras on MST2 signaling are determined by K-Ras activation kinetics.
Romano D; Maccario H; Doherty C; Quinn NP; Kolch W; Matallanas D
Mol Cell Biol; 2013 May; 33(9):1859-68. PubMed ID: 23459937
[TBL] [Abstract][Full Text] [Related]
9. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network.
Guo C; Tommasi S; Liu L; Yee JK; Dammann R; Pfeifer GP
Curr Biol; 2007 Apr; 17(8):700-5. PubMed ID: 17379520
[TBL] [Abstract][Full Text] [Related]
10. Fascin Regulates the Hippo Pathway and Is Important for Melanoma Development.
Kang BS; Lim SC
Anticancer Res; 2021 May; 41(5):2403-2410. PubMed ID: 33952465
[TBL] [Abstract][Full Text] [Related]
11. The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes.
St Louis BM; Quagliato SM; Su Y-T; Dyson G; Lee P-C
mBio; 2024 May; 15(5):e0342923. PubMed ID: 38624208
[TBL] [Abstract][Full Text] [Related]
12. Taming the Hippo: Raf-1 controls apoptosis by suppressing MST2/Hippo.
O'Neill E; Kolch W
Cell Cycle; 2005 Mar; 4(3):365-7. PubMed ID: 15701972
[TBL] [Abstract][Full Text] [Related]
13. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
14. Mammalian Ste20-like kinase (Mst2) indirectly supports Raf-1/ERK pathway activity via maintenance of protein phosphatase-2A catalytic subunit levels and consequent suppression of inhibitory Raf-1 phosphorylation.
Kilili GK; Kyriakis JM
J Biol Chem; 2010 May; 285(20):15076-15087. PubMed ID: 20212043
[TBL] [Abstract][Full Text] [Related]
15. Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt.
Romano D; Matallanas D; Weitsman G; Preisinger C; Ng T; Kolch W
Cancer Res; 2010 Feb; 70(3):1195-203. PubMed ID: 20086174
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
17. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
18. Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras.
Matallanas D; Romano D; Al-Mulla F; O'Neill E; Al-Ali W; Crespo P; Doyle B; Nixon C; Sansom O; Drosten M; Barbacid M; Kolch W
Mol Cell; 2011 Dec; 44(6):893-906. PubMed ID: 22195963
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.
Cartlidge RA; Thomas GR; Cagnol S; Jong KA; Molton SA; Finch AJ; McMahon M
Pigment Cell Melanoma Res; 2008 Oct; 21(5):534-44. PubMed ID: 18715233
[TBL] [Abstract][Full Text] [Related]
20. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
